Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease

The incidence of alcoholic liver disease (ALD) is increasing worldwide while no effective treatment has been approved. The progression of ALD has proven to be related to the upregulation of phosphodiesterase 4 (PDE4) expression, and PDE4 inhibitors showed potential to improve ALD. However, the appli...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jingyi, Kumar, Virender, Mahato, Ram I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501368/
https://www.ncbi.nlm.nih.gov/pubmed/36145643
http://dx.doi.org/10.3390/pharmaceutics14091894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501368/
https://www.ncbi.nlm.nih.gov/pubmed/36145643
http://dx.doi.org/10.3390/pharmaceutics14091894

Ejemplares similares